The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N,N'-((((1R,2R)-Cyclopentane-1,2-diyl)bis(azanediyl))bis-(1,3,4-thiadiazole-5,2-diyl))bis(2-phenylacetamide) ID: ALA4437956
PubChem CID: 155512888
Max Phase: Preclinical
Molecular Formula: C25H26N8O2S2
Molecular Weight: 534.67
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Cc1ccccc1)Nc1nnc(N[C@@H]2CCC[C@H]2Nc2nnc(NC(=O)Cc3ccccc3)s2)s1
Standard InChI: InChI=1S/C25H26N8O2S2/c34-20(14-16-8-3-1-4-9-16)28-24-32-30-22(36-24)26-18-12-7-13-19(18)27-23-31-33-25(37-23)29-21(35)15-17-10-5-2-6-11-17/h1-6,8-11,18-19H,7,12-15H2,(H,26,30)(H,27,31)(H,28,32,34)(H,29,33,35)/t18-,19-/m1/s1
Standard InChI Key: DYAGQYMZCNIYKX-RTBURBONSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
23.9704 -16.8634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7876 -16.8634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0420 -16.0866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3790 -15.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7203 -16.0866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8937 -17.3402 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
22.5567 -16.8623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3023 -16.0814 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.4851 -16.0814 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.2307 -16.8623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5193 -17.2659 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.2598 -17.2701 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.8147 -16.8520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1040 -17.2553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8208 -16.0349 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.3993 -16.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4088 -16.0261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7050 -15.6122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9933 -16.0156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9898 -16.8370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6942 -17.2471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4893 -17.2719 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.1985 -16.8659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8608 -17.3447 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
27.5244 -16.8677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2711 -16.0865 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.4539 -16.0854 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.2270 -17.2764 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.9361 -16.8701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6424 -17.2810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9387 -16.0529 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.3515 -16.8747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0562 -17.2907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7647 -16.8851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7678 -16.0670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0565 -15.6563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3508 -16.0642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
9 10 2 0
7 8 2 0
6 7 1 0
8 9 1 0
10 6 1 0
10 11 1 0
7 12 1 0
1 12 1 6
11 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
2 22 1 1
22 23 1 0
27 23 2 0
25 26 2 0
24 25 1 0
26 27 1 0
23 24 1 0
25 28 1 0
28 29 1 0
29 30 1 0
29 31 2 0
30 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 32 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 534.67Molecular Weight (Monoisotopic): 534.1620AlogP: 4.20#Rotatable Bonds: 10Polar Surface Area: 133.82Molecular Species: NEUTRALHBA: 10HBD: 4#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: 6.78CX Basic pKa: 0.06CX LogP: 4.12CX LogD: 3.23Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.24Np Likeness Score: -0.87
References 1. Finlay MRV, Anderton M, Bailey A, Boyd S, Brookfield J, Cairnduff C, Charles M, Cheasty A, Critchlow SE, Culshaw J, Ekwuru T, Hollingsworth I, Jones N, Leroux F, Littleson M, McCarron H, McKelvie J, Mooney L, Nissink JWM, Perkins D, Powell S, Quesada MJ, Raubo P, Sabin V, Smith J, Smith PD, Stark A, Ting A, Wang P, Wilson Z, Winter-Holt JJ, Wood JM, Wrigley GL, Yu G, Zhang P.. (2019) Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models., 62 (14): [PMID:31199640 ] [10.1021/acs.jmedchem.9b00260 ]